Showing results (1-10 of 389) with videos related to

Sort By:
Pageof 39
Current Medicinal Chemistry. Anti-Cancer Agents|May 29, 2003
Pharmacogenetics of irinotecanG Toffoli, E Cecchin, G Corona, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Inhibition of Pgp activity and cell cycle-dependent chemosensitivity to doxorubicin in the multidrug-resistant LoVo human colon cancer cell lineG Toffoli, G Corona, M Gigante, et al.
International Journal of Cancer|January 14, 1998
Role of folate receptor and reduced folate carrier in the transport of 5-methyltetrahydrofolic acid in human ovarian carcinoma cellsG Corona, F Giannini, M Fabris, et al.
International Journal of Cancer|May 29, 1997
Reversal activity of cyclosporin A and its metabolites M1, M17 and M21 in multidrug-resistant cellsG Toffoli, G Corona, R Sorio, et al.
The International Journal of Biological Markers|October 11, 2003
Methylenetetrahydrofolate reductase genotype in diffuse large B-cell lymphomas with and without hypermethylation of the DNA repair gene O6-methylguanine DNA methyltransferaseG Toffoli, D Rossi, G Gaidano, et al.
British Journal of Cancer|January 1, 1997
Cyclosporin A as a multidrug-resistant modulator in patients with renal cell carcinoma treated with teniposideG Toffoli, R Sorio, M Gigante, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Mechanism of multidrug resistance in human tumour cell lines and complete reversion of cellular resistanceM Boiocchi, G Toffoli
International Journal of Cancer|July 3, 1996
Cellular pharmacology of idarubicinol in multidrug-resistant LoVo cell linesG Toffoli, G Corona, F Simone, et al.
The International Journal of Biological Markers|February 17, 2017
Pharmacology of epidermal growth factor inhibitorsG Toffoli, E De Mattia, E Cecchin, et al.
The International Journal of Biological Markers|May 24, 2007
Pharmacology of epidermal growth factor inhibitorsG Toffoli, E De Mattia, E Cecchin, et al.
Pageof 39